Type II collagen epitope-specific T cell

Type II collagen epitope-specific T cells are T lymphocytes that recognize peptide epitopes—especially the glycosylated 256-270 region—of type II collagen (CII), the main structural protein of cartilage[1][2]. They are implicated in the pathogenesis of autoimmune diseases such as rheumatoid arthritis (RA) and in models like collagen-induced arthritis (CIA). These T cells are characterized by a partially tolerant state: they may have reduced proliferative responses in vitro, but maintain effector functions, including interferon-gamma (IFN-γ) secretion and the ability to help B cells produce anti-CII antibodies[1]. In RA patients and susceptible transgenic mice, immune responses are primarily directed against glycosylated forms of the CII epitope, with the glycosylated 263–270 sequence being especially immunodominant[2]. While these T cells play a central role in disease models and human autoimmunity, they are not themselves a molecular target or druggable entity, but a specialized immune cell subset with disease relevance. For studies of therapy, the relevant molecular target is the **Type II collagen (CII)** epitope or the specific MHC-peptide complex, not the T cell per se[1][2]. Additional notes: - The "target" described is a **T cell population with defined epitope specificity**, not a protein, receptor, or molecular complex amenable to small-molecule or antibody targeting. - In therapeutic contexts, attention would focus on the **collagen epitope** or the presenting **MHC class II molecule** rather than the reacting T cell itself. - There is no canonical abbreviation, and it is not found in molecular target databases as a standard target. - No approved drugs directly target these T cells, but therapies for RA (e.g., broad immunosuppressants) indirectly modulate them. No direct mechanism-of-action or specific drugs are listed in major drug reference sources. - Glycosylated CII epitope-specific T cell activity may serve as a **biomarker** for disease activity or therapy monitoring in autoimmune arthritis[2].

Other names

Type II collagen-specific T cellCII epitope-specific T cellCollagen type II-reactive T cellType II collagen (CII) peptide 256-270-specific T cell